Search Results - "Triguboff, E"

Phase II of doxorubicin/taxol in metastatic breast cancer by PAZOS, C, MICKIEWICZ, E, TRIGO, M, BERTONCIN, A. M, PASCUAL, M, URANGA, G, CAZAP, E, BREIER, S, GRASSO, S, ESTEVEZ, R, TRIGUBOFF, E, ALVAREZ, A, DI NOTTO, M. R, SUAREZ, A, COPPOLA, F, VENTRIGLIA, M, JOVTIS, S, BALBIANI, L, LEWI, D, RONDINON, M, TEMPERLEY, G

Get full text

Phase II of doxorubicin/taxol in metastatic breast cancer. Argentine Multicenter Taxol Group by Pazos, C, Mickiewicz, E, Di Notto, M R, Cóppola, F, Ventriglia, M, Jovtis, S, Balbiani, L, Lewi, D, Róndinón, M, Témperley, G, Trigo, M, Bertoncín, A M, Pascual, M, Uranga, G, Cazap, E, Breier, S, Grasso, S, Estévez, R, Triguboff, E, Alvarez, A, Suárez, A

“…To assess the response rate, survival, and toxicity of Taxol (paclitaxel) as 1-h infusion plus doxorubicin as first-line treatment for patients with metastatic…”
Get full text

Paclitaxel in platinum-resistant ovarian cancer patients. Argentine Multicenter Taxol Group by Ezcurdia, L, Jovtis, S L, Mickiewicz, E, Temperley, G, Rondinón, M, Blajman, C, Cóppola, F S, Lewi, D, Cazap, E, Breier, S, Fasce, H, Fein, L, Polera, J, Triguboff, E, Uranga, G, Pasccón, G, Luchina, A M, Martínez, C A, Politi, P M, Rubio, G, Alvarez, A M

“…Paclitaxel (Taxol; Bristol-Myers Squibb Company; Princeton, NJ) is an antineoplastic agent that inhibits microtubular function and has shown efficacy in…”
Get more information

Combination Salvage Chemotherapy with MIZE (Ifosfamide-Mesna, Idarubicin and Etoposide) for Relapsing or Refractory Lymphoma by Garay, Guy, Dupont, Juan, Dragosky, Martha, Nucifora, Elsa, Cacchione, Roberto, Schnidrig, Pedro, Fefwández, José, Abel-Alzueta, Riveros, Dardo, Noviello, Vicenta, Bègueltn, Raül, Campestri, Reynaldo, Albera, Carlos, Nicastro, Mario, Triguboff, Eduardo

“…In this study, 54 patients with relapsed or refractory non-Hodgkin's lymphoma (NHL) were treated in a phase II, multicentric trial with ifosfamide-mesna 1500…”
Get full text